Supplemented Very Low Protein Diet (sVLPD) in Patients with Advanced Chronic Renal Failure: Clinical and Economic Benefits
Nutrients · 2023
DOI: 10.3390/nu15163568 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Nutrients, 2023. Verfasst von Sofia Cecchi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical and Molecular Science, Polytechnic University of Marche, 60121 Ancona, Italy. Hauptthemen laut MEDLINE: Kidney Failure, Chronic, Renal Insufficiency, Chronic, Malnutrition. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hemodialysed National Association (ANED).
Abstract (Originalsprache)
The supplemented very low-protein diet (sVLPD) has proven effective in slowing the progression of stage 5 chronic renal failure and postponing the start of the dialysis treatment. However, sVLPD could expose the patient to the risk of malnutrition. This diet is also difficult to implement due to the required intake of large number of keto-analogue/amino acid tablets. In our Center, the Department of Nephrology and Dialysis of Azienda Sanitaria Territoriale n 1, Pesaro-Urbino, of Italy, respecting the guidelines of normal clinical practice, we prescribed sVLPD (0.3 g/prot/day) supplemented with only essential amino acids without the use of ketoanalogues in stage 5 patients and verified its efficacy, safety and clinical and economic effects. Over the 24 months period of observation the progression of chronic kidney disease (CKD) slowed down (mean eGFR 11.6 ± 3.3 vs. 9.3 ± 2.7 mL/min/1.73 m2, p < 0.001) and the start of the dialysis treatment (adjusted HR = 0.361, CI 0.200–0.650, p = 0.001) was delayed without evidence of malnutrition, in compliant vs. non-compliant patients. This led to a substantial cost reduction for the National Health System. This non-interventional longitudinal observational study is part of standard clinical practice and suggests that VLPD supplemented with essential amino acids could be extensively used to reduce the incidence of dialysis treatments, with a favorable economic impact on the NHS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical and Molecular Science, Polytechnic University of Marche, 60121 Ancona, Italy.
- Department of Nephrology and Dialysis, Ospedale Santa Croce, Azienda Sanitaria Territoriale n 1, Pesaro-Urbino, 61032 Fano, Italy.
ORCID-Profile: Silvio Di Stante
Förderung
- Hemodialysed National Association (ANED)
Zitieren
APA
Cecchi, S., Di Stante, S., Belcastro, S., Bertuzzi, V., Cardillo, A., Diotallevi, L., Grabocka, X., Kulurianu, H., Martello, M., Nastasi, V., Paci Della Costanza, O., Pizzolante, F., & Di Luca, M. (2023). Supplemented Very Low Protein Diet (sVLPD) in Patients with Advanced Chronic Renal Failure: Clinical and Economic Benefits. Nutrients. https://doi.org/10.3390/nu15163568
Vancouver
Cecchi S, Di Stante S, Belcastro S, Bertuzzi V, Cardillo A, Diotallevi L, et al. Supplemented Very Low Protein Diet (sVLPD) in Patients with Advanced Chronic Renal Failure: Clinical and Economic Benefits. Nutrients. 2023. doi:10.3390/nu15163568
BibTeX
@article{Cecchi2023,
author = {Cecchi, Sofia and Di Stante, Silvio and Belcastro, Sara and Bertuzzi, Veronica and Cardillo, Assunta and Diotallevi, Laura and Grabocka, Xhensila and Kulurianu, Hrissa and Martello, Mauro and Nastasi, Valentina and Paci Della Costanza, Osmy and Pizzolante, Francesca and Di Luca, Marina},
title = {Supplemented Very Low Protein Diet (sVLPD) in Patients with Advanced Chronic Renal Failure: Clinical and Economic Benefits},
journal = {Nutrients},
year = {2023},
doi = {10.3390/nu15163568}
}
EUVIMED